The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review
Since the World Health Organization (WHO) declared COVID-19, the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as a pandemic in March 2020, and more than 117 million people worldwide have been confirmed to have been infected. Scientists, medical professionals, and o...
Saved in:
Main Authors: | Leonny Dwi Rizkita (Author), Indwiani Astuti (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum to "The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review" [J. Pharma. Anal. 11 (2021) 265-271]
by: Leonny Dwi Rizkita, et al.
Published: (2022) -
TGF-β1 Inhibition of ACE2 Mediated by miRNA Uncovers Novel Mechanism of SARS-CoV-2 Pathogenesis
by: Ewelina D. Hejenkowska, et al.
Published: (2023) -
Regulation of miRNA content. Part 2. Degradation of miRNAs
by: A.E. Abaturov, et al.
Published: (2021) -
Exosomes and Exosomal miRNA in Respiratory Diseases
by: Shamila D. Alipoor, et al.
Published: (2016) -
Regulation of miRNA content. Part 1. Editing miRNA. Тailing miRNA
by: A.E. Abaturov, et al.
Published: (2021)